Profile data is unavailable for this security.
About the company
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
- Revenue in EUR (TTM)2.01bn
- Net income in EUR22.03m
- Incorporated1999
- Employees999.00
- LocationMedios AGHeidestrasse 9BERLIN 10557GermanyDEU
- Phone+49 30 232566800
- Fax+49 30 232566801
- Websitehttps://medios.group/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIM Vaccine Co Ltd | 154.21m | -32.87m | 421.12m | 1.49k | -- | 1.04 | -- | 2.73 | -0.2504 | -0.2504 | 1.17 | 3.05 | 0.174 | 0.7724 | 1.12 | 930,483.40 | -3.71 | -8.04 | -6.66 | -12.31 | 71.80 | 79.64 | -21.32 | -39.38 | 0.5882 | -3.70 | 0.3341 | -- | 8.22 | 6.19 | 78.69 | -- | -7.20 | -- |
| Shanghai Fudan Forward S&T Co Ltd | 80.77m | -14.54m | 435.61m | 1.41k | -- | 5.73 | -- | 5.39 | -0.1744 | -0.1744 | 0.9721 | 0.9158 | 0.4268 | 0.8015 | 9.29 | 467,663.00 | -7.83 | -3.33 | -14.36 | -5.82 | 32.05 | 39.99 | -18.35 | -7.67 | 0.4787 | -12.63 | 0.4378 | -- | -5.05 | -14.35 | -509.42 | -- | -18.59 | -- |
| Medios AG | 2.01bn | 22.03m | 436.15m | 999.00 | 19.62 | 0.8088 | 7.27 | 0.2167 | 0.8714 | 0.8714 | 78.98 | 21.14 | 2.17 | 21.52 | 12.29 | 2,006,511.00 | 2.38 | 2.59 | 3.37 | 3.09 | 9.66 | 6.53 | 1.09 | 0.8621 | 1.31 | 4.76 | 0.2765 | 0.00 | 5.51 | 29.51 | -33.29 | 5.15 | 24.73 | -- |
| Zota Health Care Ltd | 43.94m | -6.75m | 443.15m | 519.00 | -- | -- | -- | 10.08 | -23.98 | -23.98 | 157.24 | -- | -- | -- | -- | 9,108,992.00 | -- | -7.79 | -- | -10.57 | 57.22 | 42.02 | -15.34 | -8.01 | -- | -3.71 | -- | -- | 62.32 | 25.23 | -293.08 | -- | 49.40 | 0.00 |
| Beijing Kawin Technol Sha-hld Co Ltd | 140.04m | 16.71m | 454.32m | 600.00 | 27.58 | 2.03 | -- | 3.24 | 0.789 | 0.789 | 6.61 | 10.73 | 0.4166 | 1.52 | 2.64 | 1,910,937.00 | 5.26 | 5.55 | 7.12 | 7.14 | 81.89 | 84.98 | 12.64 | 9.40 | 2.55 | -- | 0.2017 | 45.97 | -12.87 | 8.32 | 22.18 | 21.60 | 40.30 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Janus Henderson Investors UK Ltd.as of 17 Oct 2025 | 1.63m | 6.39% |
| Axxion SA (Luxembourg)as of 01 Jan 2026 | 1.55m | 6.09% |
| SEB Investment Management AB (Denmark)as of 02 Jan 2025 | 1.20m | 4.70% |
| Paladin Asset Management Investmentaktiengesellschaft TGVas of 01 Jan 2026 | 613.33k | 2.41% |
| Discover Capital GmbHas of 31 Oct 2025 | 575.00k | 2.25% |
| Cr�dit Mutuel Asset Management SAas of 30 Oct 2025 | 463.00k | 1.82% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 366.50k | 1.44% |
| HC Capital Advisors GmbHas of 31 Oct 2025 | 346.70k | 1.36% |
| Kreissparkasse Biberachas of 28 Nov 2025 | 315.00k | 1.24% |
| GS&P Kapitalanlagegesellschaft SAas of 30 Jun 2025 | 310.00k | 1.22% |
